The government of the province of Buenos Aires summons volunteers who want to participate in the study of the first vaccine argentina against him covid“ArVac-Cecilia Grierson”, designed to protect against circulating SARS-CoV-2 variants in the region, including a bivalent version against Omicron.
The vaccine It is an initial development of CONICET, the National University of San Martín and the Cassará Laboratory, added to the joint effort of more than 20 public and private institutions in the country.
The study is carried out in centers in the province of Buenos Aires authorized by the National Ministry of Health and has the approval of the competent national and provincial authorities in the area.
The requirements to participate in the test are:
- Having received 2 or 3 doses of a covid vaccine.
- Being over 18 years.
- Reside in Greater Buenos Aires, La Plata or Mar del Plata
Interested parties must complete a series of data following this link. If you are selected, you will later receive information about the research center closest to your home. And, if necessary, the transfer will be facilitated.
2023-05-18 01:03:38
#Buenos #Aires #seeks #volunteers #ArVacCecilia #Grierson #vaccine #part
